Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.58% | -16.25% | -27.38% | -38.20% | -27.63% |
| Depreciation & Amortization | 59.26% | 325.00% | 5,300.00% | 4,000.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.28% | -7.50% | 10.79% | 11.61% | 20.02% |
| Operating Income | 40.28% | 7.50% | -10.79% | -11.61% | -20.02% |
| Income Before Tax | 39.45% | 34.48% | 29.87% | -892.97% | -695.30% |
| Income Tax Expenses | 31.22% | 32.68% | 40.93% | -1,434.33% | -7,971.93% |
| Earnings from Continuing Operations | 40.45% | 34.73% | 27.98% | -659.80% | -616.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.41% | -73.49% | -21.82% | -98.37% | -98.37% |
| Net Income | 40.47% | 34.67% | 27.98% | -728.94% | -736.68% |
| EBIT | 40.28% | 7.50% | -10.79% | -11.61% | -20.02% |
| EBITDA | 40.42% | -16.81% | -108.33% | -297.67% | -- |
| EPS Basic | 50.69% | 45.25% | 39.20% | -578.23% | -553.13% |
| Normalized Basic EPS | 68.68% | 37.36% | 20.73% | -23.50% | -27.60% |
| EPS Diluted | 50.69% | 45.28% | 39.24% | -575.94% | -551.07% |
| Normalized Diluted EPS | 68.68% | 37.36% | 20.73% | -23.50% | -27.60% |
| Average Basic Shares Outstanding | 20.75% | 17.20% | 20.02% | 21.90% | 23.04% |
| Average Diluted Shares Outstanding | 20.75% | 17.20% | 20.02% | 21.90% | 23.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
